Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng-Chi Huang

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of the American Heart Association|July 10, 2026
Association Between Sacubitril/Valsartan Use and Risk of Major Adverse Cardiovascular Events in Patients With Durable Left Ventricular Assist Devices: A Multi-Institutional Real-World Cohort StudyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
International Journal of Cardiology|April 17, 2026
Association between Ranolazine use and outcomes in patients with suspected MINOCA: A propensity-matched cohort studyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
Frontiers in Pharmacology|June 30, 2026
Comparative cardiovascular outcomes of renin-angiotensin system inhibitors in patients receiving maintenance hemodialysis: a large real-world cohort studyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
Cardiorenal Medicine|March 21, 2026
Comparative Effectiveness of Ivabradine Versus Digoxin in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease: A Real-World Multicenter Cohort StudyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
Mayo Clinic Proceedings|June 19, 2026
Association Between Angiotensin Receptor Blocker Use and Cardiovascular Outcomes Compared With Angiotensin-Converting Enzyme Inhibitors in Patients With Atherosclerotic Cardiovascular Disease: A Real-World Cohort StudyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
Frontiers in Medicine|June 4, 2026
Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on the risk of venous thromboembolism in patients with obesity: a real-world cohort studyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
Diabetes Research and Clinical Practice|April 20, 2026
Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on cardiovascular-kidney-metabolic stage progression: a real-world cohort studyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
BMC Cardiovascular Disorders|July 10, 2026
Tirzepatide and risk of newly diagnosed aortic stenosis in patients with obesity: a multi-institutional real-world cohort studyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
Plastic and Reconstructive Surgery|February 27, 2026
"Optimizing Perforator-Based Propeller Flap Design for Distal Leg, Ankle and Hindfoot Reconstruction: A Systematic Review and Meta-Analysis"Sheng-Chi Huang, Yun-Shan Yeh, Wen-Hsuan Chen, et al.
Drug Design, Development and Therapy|June 15, 2026
Association Between Glucagon-Like Peptide-1 Receptor Agonists and Clinical Outcomes in Patients with Chronic Obstructive Pulmonary Disease and ObesitySheng-Chi Huang, Jheng-Yan Wu, Chia-Yu Kuo, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of the American Heart Association|July 10, 2026
Association Between Sacubitril/Valsartan Use and Risk of Major Adverse Cardiovascular Events in Patients With Durable Left Ventricular Assist Devices: A Multi-Institutional Real-World Cohort StudyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
International Journal of Cardiology|April 17, 2026
Association between Ranolazine use and outcomes in patients with suspected MINOCA: A propensity-matched cohort studyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
Frontiers in Pharmacology|June 30, 2026
Comparative cardiovascular outcomes of renin-angiotensin system inhibitors in patients receiving maintenance hemodialysis: a large real-world cohort studyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
Cardiorenal Medicine|March 21, 2026
Comparative Effectiveness of Ivabradine Versus Digoxin in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease: A Real-World Multicenter Cohort StudyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
Mayo Clinic Proceedings|June 19, 2026
Association Between Angiotensin Receptor Blocker Use and Cardiovascular Outcomes Compared With Angiotensin-Converting Enzyme Inhibitors in Patients With Atherosclerotic Cardiovascular Disease: A Real-World Cohort StudyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
Frontiers in Medicine|June 4, 2026
Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on the risk of venous thromboembolism in patients with obesity: a real-world cohort studyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
Diabetes Research and Clinical Practice|April 20, 2026
Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on cardiovascular-kidney-metabolic stage progression: a real-world cohort studyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
BMC Cardiovascular Disorders|July 10, 2026
Tirzepatide and risk of newly diagnosed aortic stenosis in patients with obesity: a multi-institutional real-world cohort studyJheng-Yan Wu, Keng-Wei Lee, Sheng-Chi Huang, et al.
Plastic and Reconstructive Surgery|February 27, 2026
"Optimizing Perforator-Based Propeller Flap Design for Distal Leg, Ankle and Hindfoot Reconstruction: A Systematic Review and Meta-Analysis"Sheng-Chi Huang, Yun-Shan Yeh, Wen-Hsuan Chen, et al.
Drug Design, Development and Therapy|June 15, 2026
Association Between Glucagon-Like Peptide-1 Receptor Agonists and Clinical Outcomes in Patients with Chronic Obstructive Pulmonary Disease and ObesitySheng-Chi Huang, Jheng-Yan Wu, Chia-Yu Kuo, et al.
Pageof 2